A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Ossium Health, Inc.
Institute of Hematology & Blood Diseases Hospital, China
Ohio State University Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Affiliated Hospital of Qinghai University
Medical College of Wisconsin
Children's Hospital of Philadelphia
Sanguine Biosciences
European Institute of Oncology
Hospital Universitari Vall d'Hebron Research Institute
Boston Children's Hospital